Free shipping on all orders over $ 500

DRI-C21045

Cat. No. M25496

All AbMole products are for research use only, cannot be used for human consumption.

DRI-C21045 Structure
Size Price Availability Quantity
10mg USD 240  USD240 In stock
25mg USD 300  USD300 In stock
50mg USD 420  USD420 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

DRI-C21045 is a potent and selective inhibitor of the CD40-CD40L costimulatory protein-protein interaction (PPI) with an IC50 of 0.17 µM.

DRI-C21045 shows concentration-dependent inhibition of the activation of NF-κB and B cell proliferation all induced by CD40L with IC50s of 17.1 µM and 4.5 µM, respectively. DRI-C21045 (0.4-50 μM; 48 h) inhibits CD40L-induced MHC-II upregulation in THP-1 cells.

DRI-C21045 (30 mg/kg; s.c.; daily) prolongs graft survival in a murine allogeneic skin transplant model.

Protocol (for reference only)
Cell Experiment
Cell lines
Preparation method
Concentrations
Incubation time
Animal Experiment
Animal models Full-thickness ear skins from BALB/c were transplanted onto the dorsal thorax of C57BL/6
Formulation in 20% w/v hydroxypropyl-β-cyclodextrin (HPβCD) solution
Dosages 30 mg/kg
Administration daily, s.c.
Chemical Information
Molecular Weight 580.61
Formula C32H24N2O7S
CAS Number 2101765-81-3
Form Solid
Solubility (25°C) DMSO 2 mg/mL (Need ultrasonic)
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Damir Bojadzic, et al. Curr Top Med Chem . Toward Small-Molecule Inhibition of Protein-Protein Interactions: General Aspects and Recent Progress in Targeting Costimulatory and Coinhibitory (Immune Checkpoint) Interactions

[2] Damir Bojadzic, et al. Curr Top Med Chem. Toward Small-Molecule Inhibition of Protein-Protein Interactions: General Aspects and Recent Progress in Targeting Costimulatory and Coinhibitory (Immune Checkpoint) Interactions

[3] Jinshui Chen, et al. J Med Chem. Small-Molecule Inhibitors of the CD40-CD40L Costimulatory Protein-Protein Interaction

[4] Jinshui Chen, et al. J Med Chem. Small-Molecule Inhibitors of the CD40-CD40L Costimulatory Protein-Protein Interaction

Related TNF Receptor Products
Ozekibart

Ozekibart is an anti-TNFRSF10B monoclonal antibody.

TAPI-0 

TAPI-0 is a TACE (TNF-α converting enzyme; ADAM17) inhibitor with an IC50 of 100 nM.

Semapimod tetrahydrochloride

Semapimod tetrahydrochloride (CNI-1493), an inhibitor of proinflammatory cytokine production, can inhibit TNF-α, IL-1β, and IL-6.

BMS-566394

BMS-566394 is a potent, exceptionally selective inhibitor of TNF-α converting enzyme (TACE).

APVO603

APVO603 is a dual agonist bispecific antibody employing a novel mechanism of action to simultaneously target 4-1BB (CD137) and OX40 (CD134), both members of the TNF-receptor family.

  Catalog
Abmole Inhibitor Catalog




Keywords: DRI-C21045 supplier, TNF Receptor, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.